Study to Evaluate the Effects of Underlying Renal or Hepatic Dysfunction on the Pharmacokinetics of Nevirapine

NCT02184091 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Insufficiency
Hepatic Insufficiency

Interventions

DRUG: Nevirapine

Sponsor

Boehringer Ingelheim